TICKERNERD
Menu
HCAHCAHealthcare · Medical Care Facilities

HCA Stock Forecast: HCA Healthcare, Inc. Price Predictions for 2026-2027

Last close, 24 Aug 2026
$429
+0.01% on the day

The 25 Wall Street analysts covering HCA Healthcare, Inc. hold a median 12-month price target of $435 — +1.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 68 of 100 as at 22 Aug 2026 — in the upper half.

Market cap
$95.2B
Ticker Nerd rank
68 / 100
Median analyst target
$435
Analysts covering
25
Revenue$20.2B+8.7% y/y
Operating income$3.1B
Net income$1.9B
Free cash flow$1.1B
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+6.0%
1M
+12.3%
YTD
−7.7%
1Y
+6.7%
From 52W high
−21.0%
From 52W low
+19.0%
$361
$543
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

HCA stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores HCA Healthcare, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026
68 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Quality
91
Value
87
Volatility
85
Growth
78
Issuance
60
Momentum
52
Accruals
51
Revisions
42
Size
3

Quality (91): The business earns solid, repeatable profits on what it owns.

Revisions (42): Analysts have, on balance, been cutting their forecasts.

Size (3): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

HCA stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on HCA, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$350$400$450$500$550$600Oct 25Jan 26Apr 26Jul 26HCAHigh $579Median $435Low $380

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says25 analysts
14 Buy10 Hold1 Sell
Low $380Median $435High $579

The green dot is the last close — the median target sits +1.3% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 1 moved their price target up and 8 moved it down.

DateFirmActionRatingTarget
20 Aug 2026JP MorganMaintainsNeutral$490 → $425
3 Aug 2026Wells FargoMaintainsEqual-Weight—
3 Aug 2026Wells FargoMaintainsEqual-Weight$369 → $381
28 July 2026Goldman SachsMaintainsBuy—
28 July 2026Goldman SachsMaintainsBuy$558 → $485
28 July 2026MizuhoMaintainsOutperform$525 → $475
28 July 2026MizuhoMaintainsOutperform—
27 July 2026BairdMaintainsNeutral—
27 July 2026BairdMaintainsNeutral$396 → $393
27 July 2026BarclaysMaintainsEqual-Weight$402 → $387
27 July 2026BarclaysMaintainsEqual-Weight—
27 July 2026KeybancMaintainsOverweight—
27 July 2026KeybancMaintainsOverweight$475 → $435
27 July 2026Morgan StanleyMaintainsUnderweight$425 → $380
27 July 2026Morgan StanleyMaintainsUnderweight—
27 July 2026OppenheimerMaintainsOutperform$520 → $485
27 July 2026OppenheimerMaintainsOutperform—
27 July 2026RBC CapitalReiteratesOutperform$435
27 July 2026RBC CapitalReiteratesOutperform—
27 July 2026Truist SecuritiesMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HCA appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

HCA vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 24 Aug 2026, HCA Healthcare, Inc. returned +6.7% against +19.6% for the S&P 500, dividends included.

HCA vs S&P 500, last 12 monthsTotal return, rebased to 100
90100110120130140Oct 25Jan 26Apr 26Jul 26HCAS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

HCA analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−2.3%
Analysts raising
4
Analysts cutting
16
Fundamentals

HCA Healthcare, Inc. (HCA) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
14.4×

Cheaper than 48% of US stocks

Price / sales
1.2×

Cheaper than 66% of US stocks

Price / book
−29.1×

Cheaper than 99% of US stocks

EV / EBITDA
9.3×

Cheaper than 41% of US stocks

Growth & margins
Revenue growth (YoY)
8.7%

Higher than 48% of US stocks

Earnings growth (YoY)
2.8%

Higher than 39% of US stocks

Gross margin
44.8%

Higher than 56% of US stocks

Operating margin
15.2%

Higher than 73% of US stocks

Net margin
8.8%

Higher than 67% of US stocks

Returns & dividend
Return on equity
−244.8%

Higher than 6% of US stocks

Return on assets
12.3%

Higher than 95% of US stocks

Dividend yield
0.7%

Higher than 15% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

HCA Healthcare, Inc. (HCA) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • HCA Healthcare, Inc. has a market value of $95.2B and an enterprise value of $146.8B.

  • Revenue in the twelve months to 30 June 2026: $78.0B. The latest quarter grew 8.7% year on year.

  • Net income over the same four quarters: $7.9B, a 10.1% net margin.

  • Diluted earnings per share, trailing twelve months: $29.87.

  • Free cash flow in the twelve months to 30 June 2026: $6.0B.

  • HCA Healthcare, Inc. spent $8.7B on share buybacks and $682.0M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 218.0M.

  • Trailing P/E: 14.4×; forward P/E: 13.4× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.73%, paying out 10% of earnings.

  • HCA Healthcare, Inc. employs 230,000 people — $339K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 25 Aug 2026

Data provided by Twelve Data

Peers

HCA vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
HCAHCA Healthcare, Inc.$95.2B
68
THCTenet Healthcare Corp.$22.6B
97
EHCEncompass Health Corp.$11.9B
81
DVADaVita, Inc.$11.6B
90
UHSUniversal Health Services, Inc.$10.4B
66
ENSGThe Ensign Group, Inc.$10.4B
67
CHEChemed Corp.$7.3B
89

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own HCA Healthcare, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest HCA news & analysis

HCA Healthcare, Inc. to Present at September Conferences

Business Wire · 20 Aug 2026neutral

HCA Healthcare, Inc. announced it is scheduled to present at the Wells Fargo Healthcare Conference on September 9, 2026, and the Jefferies Healthcare Conference on September 15, 2026. Live audio webcasts and related presentation materials will be made available in the Investor Relations section of the company's website.

Why it matters — The presentations give HCA watchers an opportunity to hear directly from the company's leadership at major industry investor conferences.

HCA workers push for higher pay and more staffing amid billions in profits: ‘I'm struggling'

The Guardian · 11 Aug 2026negative

Workers at HCA Healthcare, the largest for-profit hospital system in the US, are pushing for higher pay and increased staffing while the company reports $6.8bn in profits.

Why it matters — This highlights growing tension between HCA's strong financial performance and employee dissatisfaction, which could affect operations, labor relations, and the company's public image.

HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group

Business Wire · 6 Aug 2026neutral

HCA Healthcare announced that Dr. Michael Schlosser, currently senior vice president and chief transformation officer, will become executive vice president and chief clinical officer effective Sept. 1, 2026, succeeding Dr. Michael Cuffe. Separately, Charles Gressle, president of the East Florida Division, will become president of the company's new Ambulatory Operations Group effective Sept. 1.

Why it matters — The appointments signal leadership changes in HCA's clinical leadership and a new organizational focus on ambulatory operations.

Jim Cramer Looked At This 'Not Great' Uranium Stock 'For Years'

Benzinga · 6 Aug 2026neutral

On CNBC's "Mad Money Lightning Round," Jim Cramer commented on Fortinet, Inc., saying he likes the company and that it is doing a good job. The segment also mentioned that Cramer had looked at a uranium stock "for years" that he described as "not great."

Why it matters — The news item does not mention HCA Healthcare or the healthcare sector, so it has no direct bearing on HCA watchers.

HCA SHAREHOLDER ALERT: HCA Healthcare, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

Business Wire · 4 Aug 2026negative

Kirby McInerney LLP announced an investigation on behalf of HCA Healthcare, Inc. investors into possible violations of federal securities laws or other unlawful business practices by the Company and/or its senior management. The alert references a July 14, 2026 press release in which HCA reported preliminary financial and operational results.

Why it matters — A securities-law investigation into HCA and its leadership introduces potential legal and regulatory risk for the company and its shareholders.

FAQ

Frequently asked questions about HCA stock

What is the HCA stock price forecast for 2026-2027?

The 25 Wall Street analysts covering HCA Healthcare, Inc. have a median 12-month price target of $435, with estimates ranging from $380 to $579. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is HCA stock a buy right now?

Of the 25 analysts covering HCA Healthcare, Inc., 14 rate it a Buy, 10 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks HCA Healthcare, Inc. 68 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank HCA?

As at 22 Aug 2026, HCA Healthcare, Inc. ranks 68 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (91 of 100).

Will HCA stock go up?

No one can know that. What the data says: the median 12-month target from 25 analysts implies +1.3% from the last close, and Ticker Nerd's factor model ranks HCA Healthcare, Inc. 68 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the HCA stock forecast for 2030?

No analyst covering HCA Healthcare, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HCA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $380 to $579 over the next 12 months.

How has HCA stock performed over the past year?

HCA Healthcare, Inc. returned +6.7% over the 12 months to 24 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does HCA Healthcare, Inc. do?

HCA Healthcare Inc. is a healthcare services company that operates hospitals, freestanding surgery centers, emergency care facilities, urgent care clinics, walk-in clinics, diagnostic and imaging centers, rehabilitation centers, physician practices, home health, hospice, and outpatient therapy services.

What is the latest news on HCA?

The most recent item we track (Business Wire, 20 Aug 2026): "HCA Healthcare, Inc. to Present at September Conferences". HCA Healthcare, Inc. announced it is scheduled to present at the Wells Fargo Healthcare Conference on September 9, 2026, and the Jefferies Healthcare Conference on September 15, 2026. Live audio webcasts and related presentation materials will be made available in the Investor Relations section of the company's website.

Company

About HCA Healthcare, Inc.

HCA Healthcare Inc. is a healthcare services company that operates hospitals, freestanding surgery centers, emergency care facilities, urgent care clinics, walk-in clinics, diagnostic and imaging centers, rehabilitation centers, physician practices, home health, hospice, and outpatient therapy services. It serves patients through a broad network of acute care hospitals and ambulatory sites across the United States and the United Kingdom. The company focuses on delivering inpatient and outpatient care, including medical and surgical services, emergency treatment, cardiac care, radiology, laboratory services, and physical therapy. HCA Healthcare Inc. plays a central role in organized healthcare delivery by connecting hospital-based care with community-based and specialty services, supporting access to a wide range of clinical offerings across multiple care settings.

CEO Mr. Samuel N. Hazen · 230,000 employees · United States · https://www.hcahealthcare.com